These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


207 related items for PubMed ID: 15382088

  • 21. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger R, Carroll WL.
    Cancer; 2003 Aug 15; 98(4):841-53. PubMed ID: 12910530
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
    Judware R, Culp LA.
    Oncogene; 1995 Dec 21; 11(12):2599-607. PubMed ID: 8545117
    [Abstract] [Full Text] [Related]

  • 24. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
    Xu Y, Voelter-Mahlknecht S, Mahlknecht U.
    Int J Mol Med; 2005 Jan 21; 15(1):169-72. PubMed ID: 15583844
    [Abstract] [Full Text] [Related]

  • 25. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A, Sun JM, Davie JR.
    Biochem Cell Biol; 2007 Dec 21; 85(6):751-8. PubMed ID: 18059533
    [Abstract] [Full Text] [Related]

  • 26. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1.
    Judware R, Culp LA.
    Oncogene; 1997 Mar 20; 14(11):1341-50. PubMed ID: 9178894
    [Abstract] [Full Text] [Related]

  • 27. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells.
    Repouskou A, Sourlingas TG, Sekeri-Pataryas KE, Prombona A.
    Chronobiol Int; 2010 Jun 20; 27(4):722-41. PubMed ID: 20560708
    [Abstract] [Full Text] [Related]

  • 28. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 29. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
    Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA.
    Prostate; 2006 Aug 01; 66(11):1151-61. PubMed ID: 16652385
    [Abstract] [Full Text] [Related]

  • 30. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
    Watt F, Watanabe R, Yang W, Agren N, Arvidsson Y, Funa K.
    Cancer Gene Ther; 2007 Mar 01; 14(3):287-96. PubMed ID: 17124508
    [Abstract] [Full Text] [Related]

  • 31. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
    Zhou J, Hernandez G, Tu SW, Scholes J, Chen H, Tseng CP, Hsieh JT.
    Cancer Res; 2005 Jul 15; 65(14):6089-96. PubMed ID: 16024609
    [Abstract] [Full Text] [Related]

  • 32. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 33. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray].
    Hong ZY, Yi LS, Miao XY, Lu YP, Zhou JF, Liu WL.
    Ai Zheng; 2006 Aug 27; 25(8):946-53. PubMed ID: 16965673
    [Abstract] [Full Text] [Related]

  • 34. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD.
    Cancer Res; 1994 Oct 01; 54(19):5036-40. PubMed ID: 7923112
    [Abstract] [Full Text] [Related]

  • 35. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Gao J, Chen T, Liu J, Liu W, Hu G, Guo X, Yin B, Gong Y, Zhao J, Qiang B, Yuan J, Peng X.
    Glia; 2009 Jul 01; 57(9):989-99. PubMed ID: 19062177
    [Abstract] [Full Text] [Related]

  • 36. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
    Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X, Yu Z, Gill GN, Andersen B.
    Oncogene; 2007 Sep 27; 26(44):6431-41. PubMed ID: 17452977
    [Abstract] [Full Text] [Related]

  • 37. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 38. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
    Shohet JM, Hicks MJ, Plon SE, Burlingame SM, Stuart S, Chen SY, Brenner MK, Nuchtern JG.
    Cancer Res; 2002 Feb 15; 62(4):1123-8. PubMed ID: 11861392
    [Abstract] [Full Text] [Related]

  • 39. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.
    de Ruijter AJ, Meinsma RJ, Bosma P, Kemp S, Caron HN, van Kuilenburg AB.
    Exp Cell Res; 2005 Oct 01; 309(2):451-67. PubMed ID: 16084510
    [Abstract] [Full Text] [Related]

  • 40. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.
    Mol Cancer Res; 2008 Jul 01; 6(7):1204-14. PubMed ID: 18644983
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.